TEMPOTEST-QC
An Integrated Tool-Kit for the Clinical Evaluation of Microbial Detection and Antibiotic Susceptibility Point-of-Care Testing Technologies
| Coordinatore | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Organization address
address: 's Gravendijkwal 230 contact info |
| Nazionalità Coordinatore | Netherlands [NL] |
| Totale costo | 4˙111˙659 € |
| EC contributo | 3˙064˙462 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2009-single-stage |
| Funding Scheme | CP-FP |
| Anno di inizio | 2010 |
| Periodo (anno-mese-giorno) | 2010-02-01 - 2013-05-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Organization address
address: 's Gravendijkwal 230 contact info |
NL (ROTTERDAM) | coordinator | 804˙464.00 |
| 2 |
UNIVERSITE PARIS-SUD
Organization address
address: RUE GEORGES CLEMENCEAU 15 contact info |
FR (ORSAY) | participant | 647˙040.00 |
| 3 |
UNIVERSITE CATHOLIQUE DE LOUVAIN
Organization address
address: Place De L'Universite 1 contact info |
BE (LOUVAIN LA NEUVE) | participant | 635˙298.00 |
| 4 |
UNIVERSITA' DEGLI STUDI DI SIENA
Organization address
address: VIA BANCHI DI SOTTO 55 contact info |
IT (SIENA) | participant | 560˙100.00 |
| 5 |
Consultatie Implementatie Technisch beheer BV
Organization address
address: Marspoortstraat 2 contact info |
NL (Zutphen) | participant | 344˙533.00 |
| 6 |
Quality Control for Molecular Diagnostics
Organization address
address: "Kelvin Campus, West of Scotland Science Park Block 4.01" contact info |
UK (Glasgow) | participant | 73˙027.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The TEMPOtest project proposal addresses the need to “design integrated tools for closing the gap between microbiological point-of-care technologies and actual clinical need”, by designing, developing and implementing a microbiological point-of-care “tool-kit” comprising i) a survey providing information on Europe-wide demand for point-of-care microbiological tests, ii) an archive of freely available quality control/quality assurance microbiological test samples for rapid evaluation of point-of-care microbiological tests, iii) a freely available Comparison Tool comprising specimen archive/software tool to rapidly determine sensitivity, susceptibility, reproducibility and time to diagnosis for new microbiological point-of-care technologies compared to current routine clinical microbiological protocols, iv) the optimization and development of electronic nose and antimicrobial resistance gene microarrays as future technologies for microbiological point-of-care testing and v) the development of supporting database and internet facilities.'